Drugs / Tritanrix-HepB/Hib™
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00343889 Comparator | Aug 2006 → Nov 2007 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, pertussis +1 | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tritanrix-HepB/Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00343889 ↗ |
| Modality | Vaccine | “Tritanrix-HepB/Hib™ + OPV vaccine” NCT00343889 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT00343889 ↗ |